Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19

Summary

This is a phase 2, single or multi-center, randomized, double-blind placebo-controlled study to evaluate the safety and efficacy of Rayaldee (CTAP101 Capsules) to treat adult subjects with mild to moderate COVID-19 who test positive for SARS-CoV-2.

Timeline

Start

2020-11-02

Primary completion

2021-10-08

Completion

2021-10-08

Drugs

Indications